Xie, Y., Bowe, B. & Al-Aly, Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat. Commun. 12, 6571 (2021).
Prevention, C. f. D. C. a. Post-COVID conditions: information for healthcare providers (2022).
Whitaker, M. et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat. Commun. 13, 1957 (2022).
Chen, C. et al. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J. Infect. Dis. 226, 1593–1607 (2022).
Son, K. et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur. Respir. J. 61, 2200970 (2023).
Pfaff, E. R. et al. Identifying who has long COVID in the USA: a machine learning approach using N3C data. Lancet Digit Health 4, e532–e541 (2022).
McGrath, L. J. et al. Use of the postacute sequelae of COVID-19 diagnosis code in routine clinical practice in the US. JAMA Netw. Open 5, e2235089 (2022).
Prevention, U. S. C. f. D. C. a. Clinical overview of long COVID (2024).
Organization, W. H. Post COVID-19 condition (Long COVID) (2022).
Organization, W. H. ICD-10 Version:2019 (2019).
Michelen, M. et al. Characterising long COVID: a living systematic review. BMJ Glob. Health 6, e225427 (2021).
Astin, R. et al. Long COVID: mechanisms, risk factors and recovery. Exp. Physiol. 108, 12–27 (2023).
Koc, H. C., Xiao, J., Liu, W., Li, Y. & Chen, G. Long COVID and its management. Int J. Biol. Sci. 18, 4768–4780 (2022).
Proal, A. D. & VanElzakker, M. B. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 12, 698169 (2021).
Raveendran, A. V., Jayadevan, R. & Sashidharan, S. Long COVID: an overview. Diab. Metab. Syndr. 15, 869–875 (2021).
Robertson, M. M. et al. The epidemiology of long coronavirus disease in US adults. Clin. Infect. Dis. 76, 1636–1645 (2023).
Robinson, P. Long COVID and breathlessness: an overview. Br. J. Community Nurs. 26, 438–443 (2021).
Schult, T. M., Schmunk, S. K., Marzolf, J. R. & Mohr, D. C. The health status of veteran employees compared to civilian employees in veterans health administration. Mil. Med. 184, e218–e224 (2019).
Ioannou, G. N. et al. Rates and factors associated with documentation of diagnostic codes for long COVID in the national veterans affairs health care system. JAMA Netw. Open 5, e2224359 (2022).
Campos, C. L. et al. Post-COVID-19 syndrome clinical pathway for the US Veterans Health Administration. J. Clin. Pathw. 9, 22–28 (2023).
Cornfield, J. A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. J. Natl Cancer Inst. 11, 1269–1275 (1951).
Bosworth, M. L. et al. Risk of new-onset long COVID following reinfection with severe acute respiratory syndrome coronavirus 2: a community-based cohort study. Open Forum Infect. Dis. 10, ofad493 (2023).
Galloway, A. et al. Impact of coronavirus disease 2019 (COVID-19) severity on long-term events in United States veterans using the veterans affairs severity index for COVID-19. J. Infect. Dis. 226, 2113–2117 (2022).
Pavli, A., Theodoridou, M. & Maltezou, H. C. Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Arch. Med. Res. 52, 575–581 (2021).
van Kessel, S. A. M., Olde Hartman, T. C., Lucassen, P. & van Jaarsveld, C. H. M. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam. Pr. 39, 159–167 (2022).
Cabrera Martimbianco, A. L., Pacheco, R. L., Bagattini, A. M. & Riera, R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int J. Clin. Pr. 75, e14357 (2021).
Chiappelli, F. & Fotovat, L. Post acute CoViD-19 syndrome (PACS) – long CoViD. Bioinformation 18, 908–911 (2022).
Arnold, D. T. et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 76, 399–401 (2021).
Carfi, A., Bernabei, R., Landi, F. & Gemelli Against, C.-P.-A. C. S. G. Persistent symptoms in patients after acute COVID-19. JAMA 324, 603–605 (2020).
Docherty, A. B. et al. Features of 20,133 UK patients in hospital with COVID-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ 369, m1985 (2020).
Tenforde, M. W. et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network – United States, March-June 2020. MMWR Morb. Mortal. Wkly Rep. 69, 993–998 (2020).
Ford, N. D. et al. Long COVID and significant activity limitation among adults, by age – United States, June 1-13, 2022, to June 7-19, 2023. MMWR Morb. Mortal. Wkly Rep. 72, 866–870 (2023).
Alkodaymi, M. S. et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin. Microbiol. Infect. 28, 657–666 (2022).
Nittas, V. et al. Long COVID through a public health lens: an umbrella review. Public Health Rev. 43, 1604501 (2022).
Mittal, J. et al. High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: a case-control study. Diab. Metab. Syndr. 15, 102302 (2021).
Boersma, P., Cohen, R. A., Zelaya, C. E. & Moy, E. Multiple chronic conditions among veterans and nonveterans: United States, 2015-2018. Natl Health Stat Report, 1-13 (2021).
Peghin, M. et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin. Microbiol. Infect. 27, 1507–1513 (2021).
Perez-Gonzalez, A. et al. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci. Rep. 12, 3369 (2022).
Subramanian, A. et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 28, 1706–1714 (2022).
Klein, J. et al. Distinguishing features of long COVID identified through immune profiling. Nature 623, 139–148 (2023).
Li, M. et al. Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19-convalescent individuals. J. Allergy Clin. Immunol. 149, 1225–1241 (2022).
Pandori, W. J. et al. Single-cell immune profiling reveals long-term changes in myeloid cells and identifies a novel subset of CD9(+) monocytes associated with COVID-19 hospitalization. J. Leukoc. Biol. 112, 1053–1063 (2022).
Bai, F. et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin. Microbiol. Infect. 28, 611–616 (2022).
Notarte, K. I. et al. Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: a systematic review and meta-analysis. J. Clin. Med. 11, 7314 (2022).
Thompson, E. J. et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 13, 3528 (2022).
Ho, J. Q. et al. The immune response to COVID-19: does sex matter? Immunology 166, 429–443 (2022).
Ciarambino, T., Para, O. & Giordano, M. Immune system and COVID-19 by sex differences and age. Women’s Health 17, 17455065211022262 (2021).
Ruggieri, A., Anticoli, S., D’Ambrosio, A., Giordani, L. & Viora, M. The influence of sex and gender on immunity, infection and vaccination. Ann. Ist. Super. Sanita 52, 198–204 (2016).
Fischinger, S., Boudreau, C. M., Butler, A. L., Streeck, H. & Alter, G. Sex differences in vaccine-induced humoral immunity. Semin Immunopathol. 41, 239–249 (2019).
Pennell, L. M., Galligan, C. L. & Fish, E. N. Sex affects immunity. J. Autoimmun. 38, J282–J291 (2012).
Dias, S. P., Brouwer, M. C. & van de Beek, D. Sex and gender differences in bacterial infections. Infect. Immun. 90, e0028322 (2022).
Ghosh, S. & Klein, R. S. Sex drives dimorphic immune responses to viral infections. J. Immunol. 198, 1782–1790 (2017).
O’Hare, A. M. et al. Complexity and challenges of the clinical diagnosis and management of long COVID. JAMA Netw. Open 5, e2240332 (2022).
Farmer, C. M., Hosek, S.D. & Adamson, D.M. Balancing demand and supply for veterans’ health care: a summary of three RAND assessments conducted under the Veterans Choice Act. Rand Health Q 6, 12 (2016).
Vimercati, L. et al. Association between long COVID and overweight/obesity. J. Clin. Med. 10, 4143 (2021).
Ray, J. G., Cohen, E., Butler, E. A., Grandi, S. & Park, A. Indicators of cardiometabolic function in pregnancy and long-term risk of COVID-19: population-based cohort study. Cureus 15, e35325 (2023).
Loosen, S. H. et al. Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients. Infection 50, 1165–1170 (2022).
Peter, R. S. et al. Association of BMI with general health, working capacity recovered, and post-acute sequelae of COVID-19. Obesity 31, 43–48 (2023).
Ni, S. J., Gao, J. L. & Shen, S. S. Obesity and hypertriglyceridemia: high risks for disease severity and mortality in COVID-19 patients. Acta Physiologica Sinica 74, 783–791 (2022).
Arulanandam, B., Beladi, H. & Chakrabarti, A. Obesity and COVID-19 mortality are correlated. Sci. Rep. 13, 5895 (2023).
Tadayon Najafabadi, B. et al. Obesity as an independent risk factor for COVID-19 severity and mortality. Cochrane Database Syst. Rev. 5, CD015201 (2023).
Kadowaki, T. et al. Obesity, overweight, and severe prognosis in COVID-19 patients in Japan. J. Infect. Chemother. 29, 1109–1113 (2023).
Dzifa Adjaye-Gbewonyo, P.D., M.P.H., Anjel Vahratian, Ph.D., M.P.H., Cria G. Perrine, Ph.D., and Jeanne Bertolli, Ph.D., M.P.H. Long COVID in Adults: United States, 2022 (2023).
Fiolet, T., Kherabi, Y., MacDonald, C. J., Ghosn, J. & Peiffer-Smadja, N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin. Microbiol. Infect. 28, 202–221 (2022).
